Citadel Advisors’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,661
| Closed | -$12.1K | – | 6725 |
|
|
2023
Q2 | $12.1K | Buy |
1,661
+580
| +54% | +$4.23K | ﹤0.01% | 5345 |
|
|
2023
Q1 | $10.6K | Sell |
1,081
-2,678
| -71% | -$26.2K | ﹤0.01% | 5509 |
|
|
2022
Q4 | $12.4K | Buy |
3,759
+1,941
| +107% | +$6.41K | ﹤0.01% | 5651 |
|
|
2022
Q3 | $10K | Sell |
1,818
-5,211
| -74% | -$28.7K | ﹤0.01% | 5648 |
|
|
2022
Q2 | $77K | Buy |
7,029
+3,632
| +107% | +$39.8K | ﹤0.01% | 5384 |
|
|
2022
Q1 | $62K | Sell |
3,397
-3,936
| -54% | -$71.8K | ﹤0.01% | 5836 |
|
|
2021
Q4 | $173K | Buy |
7,333
+5,876
| +403% | +$139K | ﹤0.01% | 5581 |
|
|
2021
Q3 | $84K | Buy |
+1,457
| New | +$84K | ﹤0.01% | 5955 |
|
|
2021
Q2 | – | Sell |
-1,134
| Closed | -$81K | – | 7285 |
|
|
2021
Q1 | $81K | Buy |
+1,134
| New | +$81K | ﹤0.01% | 5940 |
|